Subscribe to InsuranceNewsNet Magazine for FREE




Q4 2006 Sealy Corp. Earnings Conference Call - Final

E-mail Article Print Article Free Newsletter
 
Copyright:CCBN, Inc. and FDCH e-Media, Inc.
Source:FD (FAIR DISCLOSURE) WIRE
Wordcount:7972

OPERATOR: Good day, ladies and gentlemen, thank you for standing by. Welcome to the Sealy Corporation fiscal fourth quarter 2006 earnings conference call. [OPERATOR INSTRUCTIONS] I would now like to turn the conference to Mr. Kenneth Walker, Senior Vice President, General Counsel and Secretary. Please go ahead, sir.

KENNETH WALKER, SR VP, GENERAL COUNSEL, SECRETARY, SEALY, INC.: Good afternoon, everyone. I want to thank you for joining us on Sealy's financial fourth quarter 2006 investor conference call.

Before we begin, let me remind you that in accordance with the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, the company knows that certain matters to be discussed by members of management during this call may constitute forward-looking statements. Such statements are subject to risks, uncertainties, and other factors that may cause the actual performance of Sealy to be materially different from the performance indicated or implied by such statements. Such risks and factors are set forth in the company's annual report on form 10-K for the year ending November 27, 2005. I'll now turn the call over to Dave Mcllquham, Chairman and Chief Executive Officer of Sealy Corporation.

DAVID MCILQUHAM, CHAIRMAN, PRES, CEO, SEALY, INC.: Thank you, Ken. Good afternoon. I want to also thank all of you for joining us to talk about Sealy's fourth quarter and our full year 2006. Joining me on this call is our Chief Financial Officer, Jeff Ackerman; Larry Rogers, our new President of North America, and Mark Boehmer, our Treasurer.

Our agenda for this call is as follows: I will give you a brief business and industry overview and update on key operating initiatives. Jeff will provide a financial recap on our fourth quarter and full-year results. Then I will wrap it up, and we will open the line up for questions.

Let me start by briefly discussing this past year. Being the largest mattress manufacturer, we were able to not only overcome a challenge industry and competitive environment, but also to sustain Sealy's leadership in the market by effectively executing on our comprehensive long-term growth strategy. Our focus on our three key areas of growth, Domestic Innerspring, Specialty, and International, put Sealy in a unique position due to our broad product offering across all key price points and technologies, and provides diversity across geographies. During fiscal 2006, we achieved a number of significant milestones, positioning Sealy well going in to 2007. These include a successful IPO, the transition of more than 70% of our product line to the new federal flame retardant standards, making Sealy FR compliant ahead of most of the industry. The successful introduction of key promotional products to add volume incrementally at price points where previously we weren't as dominant. The introduction of numerous new specialty products, including a new latex collection and expanded memory foam offerings, and tremendous continued International growth and success.

In the fourth quarter, we completed our FR product transitions on Posturepedic and continued to navigate through a challenging industry and competitive environment. Sales for the fourth quarter increased 8.4% to $395.3 million. Units increased 4.9%, and average unit selling price rose 3.3%. Domestically, our sales increased 2.8% and our International business grew 26.1%. While momentum in our International business has remained strong throughout the year, we are also pleased, although still very cautious, with the positive trends in our Domestic unit volume. We have gone from a 5.9% unit decline in the second quarter to a 3.7% decline in the third quarter, and only a 1.6% decline in the most recent quarter, and we anticipate that upward trend line should continue. We remain confident there is significant opportunity to improve future performance in the coming years behind our ongoing new product initiatives and a return to more normalized industry shipments.

To provide perspective on our performance, let me provide an update on the bedding industry. The International Sleep Products Association, or ISPA, reported that total dollar sales for September through November, the period representing Sealy's fourth quarter, increased by 3.6%, while unit volume was estimated to be down 5% as reported by participating members. While not a perfect gauge, since ISPA only represents about 60% of industry sales and does not include all of the major innerspring manufacturers, it does provide an indication of industry conditions. Trends in December were similar, with ISPA reporting slight declines in revenue, units, and AUSP. These conditions are in line with what we had been anticipating: stabilization, but still somewhat soft unit trends that the domestic market has been experiencing for the past several quarters. Our competitors have remained aggressive to drive their volume, but given the financial strength of Sealy, we are committed to doing what is necessary on product introductions, pricing actions, and promotional activity to remain competitive, even at the risk of short-term margins.

We believe the key to our future performance lies in executing on three key strategies: innovation and improving new product development cycles and performance in both Innerspring and Specialty, leveraging our presence and capabilities on a worldwide scale, and driving operating improvements. Ongoing product innovation is central to increasing market share and driving revenue growth in this business. As such, Sealy maintains an ongoing stream of product introduction. In fiscal 2006, we introduced nay mayor new PosturePedic and Stearns & Foster lines that were FR-compliant, strong promotional 125th anniversary products, and a number of Specialty mattresses.

In 2007, we have continued to upgrade and enhance our offerings as we introduced 36 new models at the January market in Las Vegas, the most noteworthy of which was an extremely innovative new Stearns & Foster line. The new upper-end Stearns & Foster beds have an exciting new pillow coil-on-coil construction that provides the comfort of a traditional independent coil with the legendary support profile of Stearns & Foster. In total, there are three innovative new component introductions, which include the industry's first foam-in-case boxspring. The new Stearns & Foster product line is considerably different from the current assortment and offers five meaningful steps in the line, which should drive AUSP improvements in the brand. The result is a line of beds that has resonated very well with our retailers.

We also introduced new Posturepedic Reserve Collections mattresses, which broaden our offering in the mid-tier $599 to $899 segment. Given the major FR conversion that is happening in this industry and on most of our retailer's floors through the second quarter of this year, we expect these new beds we introduce to begin shipping mid-second quarter and in to the third quarter.

To remain fresh and appealing in order to increase market share and drive revenue growth, we recognize that continuous innovation is critical, which will mean that additional investment in research and technology is a must. We will continue to strive to reduce our development cycle and become more agile in order to serve customer needs, employ the latest in technology, and maintain an ongoing stream of product introductions. We are encouraged by our progress as demonstrated by the recent introductions of the new Stearns & Foster and Posturepedic Reserve lines at the Las Vegas market.

While innovation is the engine that propels our strategy of delivering the right product offerings across key technology areas, it is our strong brand advantage, manufacturing capabilities and our marketing and distribution strength that drives slot expansion, increased velocity and market share gains. All of these strengths combined will allow us to make significant gains in the growth categories of the industry and specifically in Specialty. Our Specialty business is continuing to grow faster than the market as we focus on driving velocity, expanding distribution, and improving our product offerings. Our new proprietary continuous flow latex plant in Pennsylvania began operations this month and should be ready to support our anticipated capacity needs in the second half of 2007. This further enhances our opportunity in latex, which is especially exciting given the strong preference consumers have shown for this product over other Specialty technologies. We also believe that our continuous flow process gives us competitive advantages in cost, service and product flexibility.

We are experiencing very positive sales momentum on our true foam, memory foam products. As part of our marketing strategy designed to increase demand and create scale by driving units, we introduced targeted price actions in January. Research and market testing determined there was a significant price elasticity in memory foam mattresses and we lowered our prices to take advantage. The actions were in line with what the majority of our retailers had been anticipating offers them a greater breadth of pricing options in this category. We are committed to offering consumers a variety of Specialty platforms and not limiting ourselves to one technology. Consumers want solutions to their sleep problems, not just different components.

The third technology in our Specialty category is air, which we are continuing to evaluate with our right touch test. This is a comprehensive market test, which includes product performance, marketing, training, distribution effectiveness and post-sales servicing that is being conducted in the U.S., Canada, and in Europe. Over the past several months, we have been putting all of the necessary elements in place, and we began measuring results in the middle of December. We expect to continue this learning and testing throughout most of 2007.

Another aspect unique to Sealy that is a competitive advantage and drives our strategy is our presence and capabilities on a worldwide scale. In December we announced a realignment of management and created a new North American division, which includes the United States, Canada, Mexico and Puerto Rico. As North America becomes more of an integrated market, this new structure should allow Sealy to better leverage our domestic product development capabilities, sales and distribution strengths and lean manufacturing initiatives across all borders.

Our performance in international markets, including Canada, Mexico and Puerto Rico, has been extremely strong this year, with sales up almost 21%, further strengthening our position as the only major U.S. bedding manufacture with a substantial company-owned international presence. Since the markets around the world vary, having a meaningful international business diversifies our revenue and our earnings stream. As in Canada, where we have leveraged Sealy's strength to build a No. 1 market share position with significant scale and highly profitable operations, we continue to progress in other international markets. For example, we grew sales in Europe more than 20% in 2006, as we expanded our latex production and distribution.

And in Mexico, we are the No. 1 luxury brand, a position that we established several years ago, and continue to expand on. Not only were sales up 24% in 2006, but we are also benefiting from relationships and insights drawn from that business. One of our large Mexican retailers is expanding in to the southwestern United States and as part of that expansion, we are becoming a North American supplier to them. Additionally, we are able to apply valuable insights from Mexico to serve the growing Hispanic population in the U.S. The scale and long-term track record of success internationally gives us confidence that our goal of generating one third of our growth from outside the U.S. is very achievable.

Another key element of our strategy is expanding our lean manufacturing efforts to drive operating improvements with resulting margin expansion. Due to the commodity nature of many mattress inputs and the inflationary environment in certain of the raw materials, we are exceptionally focused on productivity improvements, value engineering and cost reduction. In 2007, we will be expanding the lean initiatives to our plants internationally and expect to produce similar results to what we've accomplished domestically. We will also be opening a new plant in Orlando, which provides greater capacity and efficiency in serving the growing Florida market. By utilizing value engineering and design for manufacturing initiatives, we believe our lean initiative will provide additional benefits in the coming years.

I will now turn the call over to Jeff Ackerman, who will update you on our financial results.

JEFFREY ACKERMAN, EXEC VP AND CFO, SEALY, INC.: Thanks, Dave. I would now like to walk you through the fourth quarter results in more detail.

For the fourth quarter total sales were $395.3 million, an increase of 8.4% from $364.6 million for the same period a year earlier. This increase is the result of a 4.9% increase in units and a 3.3% increase in average unit selling price or AUSP. Domestic sales increased by 2.8% to $284.6 million, driven by a 4.4% increase in AUSP and partially offset by a 1.6% decrease in unit volume. The increase in AUSP is primarily due to the price increases announced at the end of the fourth quarter in the prior year. While we are not pleased with the continued decline in unit volume year-over-year, I would like to point out that we comped 8% unit growth in the prior year, and again, the trend is moving in the right direction.

Internationally, sales grew to $110.7 million, an increase of 26.1% or 18.8% on a constant currency basis. This growth was the result of strong growth in all our international businesses. The largest contribution came from our Canadian business, which was up 25.2% or 18.9% in local currency and our European business, which accelerated 33% in the quarter or 28.2% on a local currency basis. Total gross profit was $177.5 million, an increase of 11.3% or $18 million over the same period a year earlier. As a percentage of sales, gross profit expanded by 120 basis points to 44.9%. Driven by a reduction in the reserve for workers' compensation claims and improved manufacturing efficiencies, partially offset by the disproportionate planned growth of our lower margin promotional lines.





The fourth quarter gross profit includes a change in estimates underlying the reserves for workers' compensation claims. The effect of this change was a $5.7 million benefit, of which $1.2 million is related to 2006 claims. Over the past several years, Sealy has made safety a top priority in our plants and our efforts are paying off in fewer injuries and lower per incident workers' compensation claims.

SG&A increased to $6.1 million, or 5.1% from the same period a year ago, to $125.7 million. As a percentage of sales, SG&A decreased 100 basis points from the same period last year to 31.8% through effective cost management efforts.

During the fourth quarter we incurred $5.8 million of higher floor sample sales discounts and other product launch costs associated with the completion of the new Posturepedic line roll out in the U.S. As part of Sealy's strategy of constant innovation and enhancements to the product pipeline, we anticipate ongoing investment in research and technology, as well as spending to support new product introductions across our broadening product offerings and expanding distribution. While that amount will be less than the incremental $26.7 million spent in 2006, we will continue to incur product introduction costs going forward.

As we have discussed in the past, in order to maintain our industry-leading position, we will continue investing in innovation and new products, which we believe generates one of the best returns on our invested capital. In 2007, we anticipate reinvesting $15 to $20 million of the 26.7 million to support the rollout of the beds we introduces at the Vegas show in January, along with additional product introductions throughout the balance of the year. We expect the majority of the sales and launch costs associated with the beds introduced in January to be realized primarily in the second and third quarters. The FR conversion for our promotional products must be completed by June 30th and we expect the new Stearns & Foster products to be rolled out by July at the latest.

Interest expense decreased $800,000 from the same period a year ago to $19.4 million, which included $600,000 of non-cash interest expense. The reduction was primarily driven by decreases in debt partially, offset by higher LIBOR interest rates underlying our variable-rate debt. Net income was $0.22 per diluted share, or $21.5 million, up 42% from $15.2 million in the same period in 2005.

Let me now touch on a few highlights for the full year. Sealy has driven sales growth, positive unit volume, AUSP growth and gross margin expansion. For the year ended November 26th, 2006, total net sales were approximately $1.6 billion, a 7.7% increase from $1.5 million for the year earlier. This increase is a result of a 6.3% increase in average unit selling price and 1.4% increase in units. This performance breaks down domestically and internationally as follows: Domestic sales increased by $48.9 million or 4.2% driven ,by a 7.4% increase in AUSP partially offset by a 2.9% decrease in volume.

Internationally, sales grew $64.3 million or 20.8% to $373.8 million, a 17.9% increase on a constant currency basis. Gross profit increased $56.3 million to $707.9 million from a year earlier. As a percent of sales, gross profit expanded 40 basis points to 44.7%. Net income was $74 million, an increase of 8% over the prior year. Our 2006 results include $34.2 million of pre-tax expense associated with the IPO, $26.7 million of additional pre-tax product rollout costs in the U.S. associated with new product launches, a $4.5 million reduction in charges related to workers' compensation claims for prior years, and $4.5 million of pre-tax refinancing charges. We also had $4.1 million of tax benefits associated with the settlements and resolutions of certain tax liabilities.

Now, on the balance sheet, which is one of the strongest in the industry, Sealy's cash and cash equivalent balance as of November 26th, 2006, was $45.6 million, compared to $36.6 million at the same time last year. The company continues to deleverage the balance sheet and reduce debt net of cash by $149.3 million during the year to $786.9 million. Our net debt to adjusted EBITDA ratio was 3.15, as compared to 4.02 last year. The reduction in debt was attributable to strong operating cash flow and proceeds from our IPO, partially offset by $31 million in net capital expenditures and the addition of $26.5 million in financing obligations related to leases.

During fiscal 2006, we added the new latex plant in Pennsylvania and our plant under construction in Orlando to our balance sheet. In the future, we intend to employ operating leases to fulfill our facility requirements. Additionally during fiscal 2006 we capitalized the long-term licensing agreement with Pirelli, a brand that we license in Europe, which we will amortize over the life of the agreement at a rate of approximately EUR2 million per year. We are able to maintain relatively low levels of working capital and have initiatives to make improvements on each component.

Looking at our accounts receivable during the fourth quarter of 2006, our Domestic days sales outstanding was 34 days which was one day higher than the same period a year ago. International days sales outstanding improved by two days over the prior year. Our Domestic days inventory on hand increased by 3 days to 28 days from the prior year. This increase was driven by a buildup in our foreign-sourced inventories to support the Specialty Bedding category. We expect days-on-hand to improve at the startup of the domestic latex plant which will reduce our reliance on imports. Internationally, days-on-hand was flat. Our Domestic days' payable was 64 days, a decrease of four days as compared to the same period a year ago. International days payable was up nearly one day.

Next I would like to remind you that this is a steady business that delivers substantial cash flow, with low-maintenance CapEx and minimal working capital requirements. On an ongoing net basis, we evaluate our capital needs and determine the best use of cash. As we approach our target leverage ratio of 2.5 to 3 times total net debt to adjusted EBITDA, we have been discussing with our Board of Directors the preferable use of cash going forward in order to provide the best return to our shareholders. The company's priorities for the use of cash flow include investing in our strategic initiatives and product innovation and the payment of dividends.

Additionally, we are pleased to announce Sealy's Board of Directors has approved a share repurchase program, authorizing the company to repurchase up to $100 million of its common stock. We believe that this repurchase program reflects our commitment to return a portion of excess cash to our shareholders while maintaining our targeted net debt levels and preserving flexibility to fund our continued growth plans. In fiscal 2006, our cash capital expenditures were $31 million, and in 2007, we expect capital expenditures to be approximately 2% of our revenues, which is in line with our historical average.

Finally, I'd like to briefly discuss our outlook and a few things to keep in mind when modeling Sealy's fiscal 2007. We remain focused on execution of our product line initiatives, ongoing innovation, improves to our product refresh cycle and cost management. Given our current outlook, we expect our performance will be impacted by the aggressive competitive environment, ongoing strength in our promotional and Specialty lines, a transition period leading up to shipping our new Stearns & Foster line and Posturepedic Reserve beds, which will only truly start impacting our results in a positive manner the last few weeks of the second quarter and beyond, and finally, the ramping up of our domestic latex plant during the first half of the year. We are encouraged by the current trend in Domestic unit volume, and continue to be pleased by the strength in our international markets.

As a reminder, our business can be somewhat volatile on a quarter-to-quarter basis, but our long-term targets remain intact. Over the long term, we anticipate achieving our targets of sales growth in the mid-to-high single digits, an average of 20 to 50 basis points of gross margin expansion, 10% EBITDA growth and EPS growth in the mid-teens. For 2007, we anticipate being able to realize additional benefits totaling $4 to $6 million over our normalized effective tax rate of 38%. And lastly, I want to make you aware that fiscal 2007 is a 53-week year for us.

I will now turn the call back over to Dave to provide some concluding comments.

DAVID MCILQUHAM: Thanks, Jeff.

Before we take questions, I want to remind you of a few things. Sealy is the largest mattress manufacturer with a unique competitive position due to our scale, breadth of product offerings and diversity of geographies.

With the implementation of our recent management realignment and with FR compliance largely behind us, we are optimistic going in to 2007, focused on our execution, and ensuring that we have the right products in the stores at all times. We are particularly excited about the opportunity in the second half of the year, as our new latex plant in Pennsylvania becomes fully operational and the innovative new Stearns & Foster and Posturepedic Reserve products are established on our customer's floors.

The opportunity for continued sales growth, margin expansion, and earnings momentum is clear, and as we pursue the opportunities in front of us, we expect to not only maintain our market share leadership position in the bedding industry, but extend it as we seek to increase shareholder value over time. With that, we will open up the lines and take questions.

OPERATOR: Thank you. [OPERATOR INSTRUCTIONS] We'll take our first question from Stephen Kim with Citigroup.

STEPHEN KIM, ANALYST, CITIGROUP: Thanks, guys. Good job.

DAVID MCILQUHAM: Hey Stephen.

STEPHEN KIM: Hi. Had one basic question and a few sort of housekeeping items. Let me save the housekeeping for last. You gave some Domestic AUSP data, and you also talked about Domestic units, Domestic unit trends. First of all, I guess I was wondering if you could articulate whether your AUSP across all of your major product categories, let's say-- the different technologies, if you will, like the innerspring, and the air, and-- not really air, but the-- the viscoelastic and the latex, did they all experience AUSP growth? Was it roughly comparable? Or did some grow and some decline?

JEFFREY ACKERMAN: Yes, Stephen, this is Jeff. For competitive reasons we're not giving, really, any information about pricing on a product-line basis.

STEPHEN KIM: Okay. Let me try another one then. You talked about a Domestic unit growth in the quarter, and you said it was down 1.6%. Can you give us a sense for how things have trended sort of at the end of the quarter, as you head in to earlier this year. Have you gotten to the point where you were sort of flat year-on-year?

JEFFREY ACKERMAN: As I mentioned, Stephen we were comp an 8% growth from the prior year, so we were -- being down in the quarter 1.6% on a two-year basis that still puts us up 6% on units for the domestic market.

STEPHEN KIM: Yes. I guess what I'm saying, though, is if you extended that and looked at the period month-by-month or looked at in January and February, whether those trends improved from the numbers you saw in the fourth quarter as a whole?

JEFFREY ACKERMAN: You know, I really don't have that the monthly data here with me.

OPERATOR: Okay. We'll go to our next question from Al Kabili with Goldman Sachs.

ALBERT KABILI, ANALYST, GOLDMAN SACHS: Good afternoon, guys.

DAVID MCILQUHAM: Hey, Al.

ALBERT KABILI: A question on the International trends, clearly very strong, but it becomes more difficult comps this year. Could you talk a little bit about how much of the International is driven by expanded distribution last year and what should we be looking for this year in terms of growth out of International?

DAVID MCILQUHAM: Al, it's Dave. I think we have consist importantly said, that a. we don't expect to continue the trends in perpetuity like we have seen in the last year to two years internationally. That's for sure. But we continue to believe that we can drive a third of our overall growth from outside the U.S., and generally, it varies market-by-market. We just continue to outperform the market in Canada and Mexico, and in South America. In Europe, we did have some increased distribution that was in line with the expansion of our production facilities in Italy last year, and all-in-all, we believe we can continue to drive that one third of our growth from outside the U.S.

ALBERT KABILI: Okay. But no definitive-- how much does this sort of decelerate going forward? Is this still double-digit growth or -- any sort of guidance on that?

JEFFREY ACKERMAN: Well, Al, it's Jeff. As we've said, we remain committed to a third of our growth being from International. So that will continue to be the case, and given that it's a smaller piece of the business, it's-- in order to drive that one third of the growth, obviously it will be growing faster than the domestic market, and that's consistent with how it's performed for the last five years.

OPERATOR: Thank you. We'll take our next question from Keith Hughes with Robinson Humphrey.

KEITH HUGHES, ANALYST, SUNTRUST ROBINSON HUMPHREY: Thank you. Just on the quarter, you talked about some workers' compensation expense of $5.7 million and $1.2 million. Can you just go in to a little more detail on what that specifically encompasses?

DAVID MCILQUHAM: Sure, Keith. What we really have is two pieces. One is we have now as a company, working with our actuaries, have developed enough of our own history, loss history, and we're able to use that, as opposed to some actuarial standards and the focus that we've had on safety has really paid off. We've seen a continuing decline in not only the frequency, but the severity of accidents that we've had. So that's a change in estimate. So, $4.5 million of the $5.7 million relates to really prior year's performance, and prior year's claims, and $1.2 million relates to our performance in 2006 around addressing safety and driving down workers' comp claims.

KEITH HUGHES: The income statement is going to come up to the $5.7 million benefit for the fourth quarter, is that right?

DAVID MCILQUHAM: That's right.

KEITH HUGHES: And your interest expense, I believe you said was $19 million in the quarter. Does that include some non-cash expenses, as well?





DAVID MCILQUHAM: Yes, $600,000.

KEITH HUGHES: $600,000. Okay. And a little bit longer-term question, you've recently done some pricing actions on your viscoelastic product. Has that already been rolled out to the retailers? And if so, have you had any kind of reaction on that?

JEFFREY ACKERMAN: Yes, we rolled out the pricing actions to the retailers on or about January the 8th, and we have seen some reaction to that as Dave mentioned in his opening statements. We believe that there was price elasticity in the visco's category, and we're experiencing that elasticity.

OPERATOR: Thank you we're go next to John Baugh with Stifel Nicolaus.

JOHN BAUGH, ANALYST, STIFEL NICOLAUS & COMPANY, INC.: Good afternoon. Congratulations. My question is surrounding gross margins that exclude the workman's comp. I guess it was fairly comparable to the year, maybe slightly below, or fairly comparable. Was it very strong internationally and weaker domestically? I know you're not going to give us numbers, but some kind of flavor for what drove the gross margin exclusive of workers' comp.

DAVID MCILQUHAM: We were actually the gross margins were-- just a second-- were-- internationally we were up slightly, and in the U.S., we were also up.

JOHN BAUGH: Okay. And then help me, again, just the pricing a year ago, the magnitude and the timing of all of that, and when did we exactly anniversary that?

DAVID MCILQUHAM: The pricing took effect about mid-November so it was the last couple weeks of the fourth quarter.

JOHN BAUGH: Thank you.

OPERATOR: I'll go next to Kevin [Zietz] with Goldman Sachs.

KEVIN ZIETZ, ANALYST, GOLDMAN SACHS: Hi. Thanks for taking the call. On the stock repurchase program. I was wondering if you could clarify whether that is -- is the $100 million the sort of final thought process on what to do with our cash and how to think about the long-term capital structure? Or is this an interim step and should we expect more?

JEFFREY ACKERMAN: We will continue to assess our best use of free cash flow, and this is what-- what we're prepared to do now based on our discussions with the board.

KEVIN ZIETZ: Okay. And just as a follow-up, could you clarify the size of the RP basket? I guess as of the end of the quarter and what size the carve-out is for stock dividends?

JEFFREY ACKERMAN: The RP basket is $125 million and the carve-out for the dividends is $30 million.

OPERATOR: Thank you. We'll take our next question from Karru Martinson with CIBC World Markets.

KARRU MARTINSON, ANALYST, CIBC WORLD MARKETS: Good morning-- good afternoon sorry. On promotional pricing, it sounds like you've taken more than you were expecting on the lower end of the market. I was wondering if you could give an update how you see that market progressing and also your market share there. I was seeing some 99 promotional pricing out there on the market.

DAVID MCILQUHAM: Karru, I'll take this one. It's Dave. We have consistently said and looked at the promotional segment, and that's really the $500 retail price category and below, as an opportunity for us. We have historically been under-represented in that, but we're being very selective in terms of distribution, because clearly we want any gains at that end to be incremental, and we introduced the new 125th anniversary products. They have gone incredibly well.

And I think fair to say, to use your words, probably exceeded our expectations a little bit in 2006, but we're very mindful of making sure that any activity that we have there truly is as incremental as possible, and we do that by really targeting specific opportunities on an account-by-account basis. We think we'll continue to do that, but clearly, that's part of the component as to where we get a third of our innerspring growth from in the domestic market.

KARRU MARTINSON: And just on the -- perhaps you said it. Maybe I missed it. The amortization of intangibles was up significantly on a year-over-year basis. Can you provide a little color on that?

JEFFREY ACKERMAN: The amortization on the intangibles is being driven by this licensing agreement, and that's the biggest item. That's the Pirelli agreement we talked about.

OPERATOR: We'll go next to Reza Vahabzadeh with Lehman Brothers.

REZA VAHABZADEH, ANALYST, LEHMAN BROTHERS: As far as the -- your pricing and promotional posture, I'm wondering with all of the actions that you have taken that you feel like this is the right place to be at this point in time? Or do you think there's more pricing actions to be taken one way or another in the coming period?

JEFFREY ACKERMAN: I'm going to have Larry take that one.

LAWRENCE ROGERS, PRES OF NORTH AMERICA, SEALY, INC.: This is Larry, as Jeff said. As David alluded to, we have taken a targeted approach to this, where we have selected customers that are already doing business with us that participate in this promotional sector. We don't go out and indiscriminately blow our promotional products to the marketplace. So it's a very targeted approach, and we continue to remain on that path.

REZA VAHABZADEH: Okay. And then on the growth margin front, was the improvement year-over-year just due to the increase in the European business or was it due to mix, or was there also any realization of lower raw material costs?

JEFFREY ACKERMAN: Yes, there were not a lot of changes relative to raw material costs. Actually it's the opposite. If you look at what happened to material costs versus the prior year, there's a significant increase on foam, and that is one of our -- by far our largest raw material. So the manufacturing team, through their focus on continuous improvement and execution on lean principals, they were able to drive a lot of offsets to that and as I mentioned, before the International business was up -- the margins were up just slightly.

OPERATOR: We'll take our next question from Alexis Gold with UBS.

ALEXIS GOLD, ANALYST, UBS: Hi, good afternoon.

JEFFREY ACKERMAN: Hey, Alexis.

ALEXIS GOLD: Just a couple of questions, just as we look at the changes in the retail environment, I know Mattress Firm was recently purchased, and they were one of your big retailers, can you give us a sense for whether or not you think that has any impact or benefit to the business?

JEFFREY ACKERMAN: We don't comment on what our customers are doing and what changes might be occurring in their business and how it might affect their strategy.

ALEXIS GOLD: I guess-- you have talked a lot about International, can you talk maybe a little bit about where you see -- just category-wise -- potential floor space opportunities for new products.

JEFFREY ACKERMAN: Alexis, would you just repeat that question, please?

ALEXIS GOLD: Sure. I was just trying to understand. Are there any specific categories, whether in the sleep stores or the furniture retailers? Right now I feel like we have seen ramp-up in furniture actually where you see opportunities to gain floor space.

JEFFREY ACKERMAN: Was that referring to International or Domestic?

ALEXIS GOLD: No, Domestic.

JEFFREY ACKERMAN: Okay. I don't think that there's anything specific that is happening from a channel perspective that is dramatically different from the trends over the last year or two. There's no question that sleep shop chains like Mattress Firm and Sleep Ease, Sleep Train on the West Coast for example, are three -- I guess Mattress Giant is another one -- are growing faster than the market, but overall as a percent of channel sales -- in some cases-- and I think an example last week of Mattress Firm acquiring another sleep shop chain isn't driving the kind of growth in the sleep shop channel that we saw back in the '90s. So overall the channels are pretty stable, and we don't see that changing much.

ALEXIS GOLD: Okay. And just as we look at pricing for '07-- I know you talked about it a little bit, but just as we look at the new stable of products that you are offering, should we expect that, across the board, at least as we look at higher pricing categories, that we would expect pricing in aggregate to be up in '07?

JEFFREY ACKERMAN: We're focused in '07 in making sure we have got absolutely the best product values out there, and we're looking at driving slot velocity, and we don't see any material inflation aberrations in 2007 that we experienced in the last couple of years with foam and steel. So we expect pricing to be fairly stable in '07, unlike it has been in past years, particularly given the introduction of FR products. And we think that most of the gains that might happen in AUSP in 2007 will likely be AUSP-driven as opposed to price-- I mean, that will be mixed-driven as opposed to price.

OPERATOR: Thank you. We'll take our next question from George Chalhoub with Deutsche Bank.

GEORGE CHALHOUB, ANALYST, DEUTSCHE BANK: David, just so I understand, if we're looking at the fiscal year, how are you kind of expecting it to evolve? It seems to me the comments of being more back-end loaded in terms of EBITDA performance is purely based on the roll-out costs you're going to be incurring at the early part of the year, but it seems to me that the top line, given your strategic changes that you have made, mostly on the Specialty side, the top line growth -- we should see that happening as early as early part of fiscal '07. Is that the right way to look at things?

DAVID MCILQUHAM: George, we don't comment and give quarterly guidance, but -- you've kind of read I think how 2007 is going to roll out when you say it's going to be more back-end loaded. There's no question that the industry has not emerged yet from the unit softness that we have seen in the last few quarters, and the December numbers just came out from ISPA, and it actually showed units, as well as revenue, as well as AUSP down. And I think it's going to be the second half of the year before the industry really starts to return to normal kind of trends and performance. Clearly, as Jeff mentioned, we were anniversarying some big unit gains a year ago, and it's going to take until the second half, 'til we get the latex plant up and running, until we get the new Stearns & Foster line rolled out, and we're going to go through a pretty major transition in the second quarter as we convert to the new Stearns line, the new Reserve Posturepedics and we change out all of the promotional beds to get ready for FR.

GEORGE CHALHOUB: Okay. Besides the two very obvious uses of cash for fiscal '07, which clearly is stock buybacks as announced this afternoon, and potential debt reduction -- and I'm sure you're going to balance that depending on what you feel is most economically sensible to you -- are there any small pockets of strategic opportunities that you may be looking at in some areas where you feel you may be better off just buying some small capacity versus just rolling out. I.E. you like some area like the Specialty side of the business -- is there a chance to buy something -- and I'm not necessarily saying a [inaudible] good business in size -- but to kind of fill in pockets where you feel you may have a faster way to have a big foothold and less drop in growth?

JEFFREY ACKERMAN: George, this is Jeff. Look, we feel like what we have in latex -- we have proprietary process for manufacturing latex, and we believe that's the low-cost way to do it. And so we're committed to that path. Beyond that, we're always assessing our supply chain.

OPERATOR: We'll go next to Stephen Kim with Citigroup.

STEPHEN KIM: Thanks. Just had a couple of follow-up questions. The $5.7 million associated with the workers' comp, how much of that was net? I mean, what was the tax impact on that?

JEFFREY ACKERMAN: I think on a net basis, you could use a 38% tax rate. And like I said about $4.5 million of that related to the prior year.

STEPHEN KIM: Right. But 38% tax rate would be fine. And then you mentioned 53 weeks in the year. Is there going to be a quarter which has 13 weeks and one that has 14 or how is that going to work?

JEFFREY ACKERMAN: Actually the first three quarters will have 13 and the fourth quarter will have 14.

OPERATOR: We'll go next to Keith Hughes with Robinson Humphrey.

KEITH HUGHES: Just one follow-up. Jeff, will you be posting a quarterly income statement on a website or emailing out or anything like that?

JEFFREY ACKERMAN: No, we'll be filing the K --

KEITH HUGHES: That usually doesn't have a quarterly break out. Maybe a few numbers.

JEFFREY ACKERMAN: Other than what we have in the K now, we weren't anticipating doing that.

KEITH HUGHES: Can you tell me what the average diluted share count was in the fourth quarter?

JEFFREY ACKERMAN: If you give me just a minute, I'll come back with that.

KEITH HUGHES: Okay.

JEFFREY ACKERMAN: Anything else, Keith?

KEITH HUGHES: No, that's all. Thank you.

JEFFREY ACKERMAN: Okay. I'll get you that in just a minute.

KEITH HUGHES: Okay. Thank you.

OPERATOR: We'll go next to Al Kabili with Goldman Sachs.

ALBERT KABILI: Hi, guys, also a couple of quick follow-up questions. On the workers' comp, so the $1.2 million, that-- you should see that savings also flow through in '07? Is that how we should think about it? Because you have sort of reversed, sort of, your expense there, but presumably, going forward, you are going to be booking things at a lower rate.

JEFFREY ACKERMAN: That's correct. So going forward, we're going to be able to use our own loss development factors and then also just the improving performance that we have got allows us to take $1.2 million out of the current year. We've demonstrated for quite sometime now the improvements in safety over time, so we don't see any reason why that should change.

ALBERT KABILI: Okay. Great. Thanks. And then on the Pirelli, is that what's driving the spike in D&A, sequentially, in the fourth quarter, as well as the royalty income?

JEFFREY ACKERMAN: That's a piece of it. The Pirelli piece is an amortization of intangibles.

ALBERT KABILI: Okay. So what should we be looking for for the new sort of D&A rate in '07? If you could provide some outlook there for us.

JEFFREY ACKERMAN: As I said before, our CapEx for the year is going to be in the 2% range of sales. At this moment that's all I can really provide you.





OPERATOR: Thank you. We'll go next to Reza Vahabzadeh with Lehman Brothers.

REZA VAHABZADEH: You touched on this before, but just to flesh it out and confirm it. Do you anticipate total raw material costs to be relatively flat in 2007? Any potential for benefits?

JEFFREY ACKERMAN: I don't know, Reza, there's clearly some volatility, but at this point we're seeing fairly stable pricing on raw materials, but things change all the time.

REZA VAHABZADEH: Do you usually hedge or otherwise forward-contract any of your input cost?

JEFFREY ACKERMAN: No, we have supply agreements with key suppliers and we lock in prices usually on a quarterly basis, but we do not utilize forwards, and okay? I did want to get back to Keith's question on the diluted share count for the quarter was at 96.7 million.

OPERATOR: Thank you. And at this time it appears there are no further questions. I would like to turn the program back over to Dave Mcllquham for any additional or closing remarks.

DAVID MCILQUHAM: Great. Listen, we really do want to thank you for your participation here this afternoon. I thought we had a great discussion of the business, good questions, and we are focused on executing against our key initiatives in terms of International growth, Specialty growth, and driving innerspring velocity in the domestic market. We're focused on our product development pipeline and getting these new products to market.

I'm encouraged and excited by the agility we've demonstrated in the last few months, as we brought these 36 new products to market at the Las Vegas market. And we're committed to the lean journey and the fact that with the new organization structure, we've got a terrific new leadership team in place in North America with Larry and Mike Hoffman, and we feel very good about our ability to meet our long-term commitment of growing our business in innerspring, Specialty and internationally in delivering increased shareholder values. So, thanks for your support and your participation, and we'll see you on our first quarter call.

OPERATOR: That does conclude today's conference. You may disconnect your line at anytime.

[Thomson Financial reserves the right to make changes to documents, content, or other information on this web site without obligation to notify any person of such changes.

In the conference calls upon which Event Transcripts are based, companies may make projections or other forward-looking statements regarding a variety of items. Such forward-looking statements are based upon current expectations and involve risks and uncertainties. Actual results may differ materially from those stated in any forward-looking statement based on a number of important factors and risks, which are more specifically identified in the companies' most recent SEC filings. Although the companies may indicate and believe that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate or incorrect and, therefore, there can be no assurance that the results contemplated in the forward-looking statements will be realized.

THE INFORMATION CONTAINED IN EVENT TRANSCRIPTS IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE CONFERENCE CALLS. IN NO WAY DOES THOMSON FINANCIAL OR THE APPLICABLE COMPANY OR THE APPLICABLE COMPANY ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY EVENT TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S CONFERENCE CALL ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.]

[Copyright: Content copyright 2007 Thomson Financial. ALL RIGHTS RESERVED. Electronic format, layout and metadata, copyright 2007 Voxant, Inc. (www.voxant.com) ALL RIGHTS RESERVED. No license is granted to the user of this material other than for research. User may not reproduce or redistribute the material except for user's personal or internal use and, in such case, only one copy may be printed, nor shall user use any material for commercial purposes or in any fashion that may infringe upon Thomson Financial's or Voxant's copyright or other proprietary rights or interests in the material; provided, however, that members of the news media may redistribute limited portions (less than 250 words) of this material without a specific license from Thomson Financial and Voxant so long as they provide conspicuous attribution to Thomson Financial and Voxant as the originators and copyright holders of such material. This is not a legal transcript for purposes of litigation.]



This is a news service of Thomson Business Intelligence Service ©2006. This content is for your personal use only, subject to Terms and Conditions. No redistribution allowed.



Back to Top E-mail Article Format for Printing




Free Newsletter
Edit My Newsletters
Advertising Info
PR/Press Release Service
Add INN To Your Website


Insurance Newswires
FREE L&H Magazine
Multimedia Center
International News    Premium Content
Law & Regulation    Premium Content
Reinsurance News    Premium Content
Technology News    Premium Content



Insurance Newswires
A.M. Best Affirms Ratings of Mondial Assistance International AG and Jefferson Insurance Company
Medical Properties Trust, Inc. in Settlement of Litigation
IL The Allstate Found
Analyst Choice Initiates Independent Research Coverage on the Financial, Services and Consumer Goods Sector
James Scott Farrin Attorney Rick Fleming to Speak at Conference
Seattle hospital says it may not accept insurer
Wall St Sense Unbiased Analysis on WellPoint Inc., NYSE Euronext Inc., Coventry Health Care Inc., National Oilwell Varco Incorporated, Total System Services Inc. and MGIC Investment Corp.
Tower Group CFO Colalucci to retire in March
Fairfax Voluntarily Delisting From NYSE
RiskMetrics Group Releases 2010 Proxy Voting Updates

Health Insurance Quotes
Find a plan today! View quotes online. Get expert advice absolutely free.

Discover the power of knowledge and boost your sales in 2009
Get all your news in one convenient format - the new InsuranceNewsNet Magazine.
Subscribe now FREE.

Free Insurance Leads
Free 12-Part Marketing Course Reveals All...

Tired of Committing to Unproven Health Leads?
ASAP Quotes: Quality Health Leads The Way You Want Them. No Contract. No Minimums. No Pressure.


SUBSCRIBE      ADVERTISING      ABOUT US      PRIVACY      TERMS & CONDITIONS          














Insurance News Net Site Map